Home › Funds › Vivo Capital, LLC › TNGX

Vivo Capital, LLC position in TNGX

TANGO THERAPEUTICS INC · Health Care

Vivo Capital, LLC reported holding 1,379,769 shares of TNGX (TANGO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$34.4M, representing 3.91% of its reported portfolio and ranking #9 among its reported holdings. Vivo Capital, LLC has disclosed TNGX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)1.38M sh
Reported value held$34.43M
Portfolio Weight3.91%
First reportedQ2 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's TNGX position evolved

Vivo Capital, LLC first disclosed a stake in TNGX in Q2 2025 at 600,000 shares (US$3.1M). The position peaked in Q1 2026 at 2,154,780 shares, worth US$45.1M. Across 6 filings, Vivo Capital, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,379,769 shares valued at US$34.4M. Notable position changes include a 29% increase in Q3 2025 (shares rose 5% over the following quarter), a 177% increase in Q4 2025 (shares rose 136% over the following quarter), a 36% trim in Q2 2026 (shares fell 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 600.00K $3.07M New
Q3 2025 776.70K $6.52M Add
Q4 2025 2.15M $19.09M Add
Q1 2026 2.15M $45.08M Hold
Q2 2026 1.38M $43.13M Reduce
Q3 2026 1.38M $34.43M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNGX and 13F data

TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in TNGX — the largest reported positions include RTW INVESTMENTS, LP (US$434.5M), Farallon Capital Management (US$383.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$383.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNGX

All TNGX fund holders →

FAQ

How long has Vivo Capital, LLC held TNGX?

Vivo Capital, LLC has disclosed TNGX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Vivo Capital, LLC's current position in TNGX?

As of Q3 2026, Vivo Capital, LLC holds 1.38M shares of TNGX (TANGO THERAPEUTICS INC), valued at $34.43M, representing 3.91% of its reported portfolio and ranking #9.

Has Vivo Capital, LLC been buying or selling TNGX?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC held unchanged its position in TNGX. The position peaked in Q1 2026 at 2.15M shares.

Which other funds hold TNGX?

Other major institutional holders of TNGX include RTW INVESTMENTS, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.